FDA Issues Emergency Use Authorizations to Hologic and LabCorp
FDA has issued emergency use authorizations to Hologic for its Panther Fusion SARS-CoV-2 assay and to LabCorp for its Covid-19 RT-PCR test.
Read MoreSearch Results for: covid-19
FDA Allows BioMedomics’ SARS-CoV-2 Serology Tests for Diagnostic Use
Posted by | Mar 21, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The covid-19 antibody test works in 15 minutes, and features an intuitive visual interpretation. No special equipment is needed.
Read MoreHologic’s Molecular Test for the Novel Coronavirus, SARS-CoV-2, Receives FDA Emergency Use Authorization
Posted by | Mar 18, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Hospital, public health, and reference laboratories can perform the test on Hologic’s Panther Fusion system, a fully automated, high-throughput molecular diagnostic platform that is widely used across the United States.
Read MoreSight Diagnostics’ Olo Deployed in Israeli Hospital to Help Support Coronavirus Quarantine Measures
Posted by | Mar 17, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Olo, a compact blood analyzer from Sight Diagnostics, Tel Aviv, Israel, has been installed in Sheba Tel Hashomer’s special quarantined lab to support the management of coronavirus patients.
Read MoreCoronavirus Spreads Quickly and Sometimes before People Have Symptoms, Study Finds
Posted by | Mar 17, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Research |
Time between cases in a COVID-19 chain of transmission is less than a week; more than 10% of patients are infected by somebody who is not yet symptomatic.
Read More